Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort

Abstract

using data from the European Prospective Investigation into Cancer and Nutrition cohort of 477,206 participants from 10 European countries. Methods After 11.4 years of follow-up, 191 HCC, 66 IHBC and 236 GBTC cases were identified. Hazard ratios and 95 % confidence intervals (HR; 95 % CI) were estimated with Cox regression models with multivariable adjustment (baseline total energy intake, alcohol consumption and intake pattern, body mass index, physical activity, AbstractPurpose The aim of the study was to assess associations between intake of combined soft drinks (sugar sweetened and artificially sweetened) and fruit and vegetable juices and the risk of hepatocellular carcinoma (HCC), intrahepatic bile duct (IHBC) and biliary tract cancers (GBTC) Results No risk associations were observed for IHBC or GBTC. Combined soft drinks consumption of >6 servings/ week was positively associated with HCC risk: HR 1.83; 95 % CI 1.11-3.02, p trend = 0.01 versus non-consumers. In sub-group analyses available for 91 % of the cohort artificially sweetened soft drinks increased HCC risk by 6 % per 1 serving increment (HR 1.06, 95 % CI 1.03-1.09, n cases = 101); for sugar-sweetened soft drinks, this association was null (HR 1.00, 95 % CI 0.95-1.06; n cases = 127, p heterogeneity = 0.07). Juice consumption was not associated with HCC risk, except at very low intakes (<1 serving/week: HR 0.60; 95 % CI 0.38-0.95; p trend = 0.02 vs. non-consumers). Conclusions Daily intake of combined soft drinks is positively associated with HCC, but a differential association between sugar and artificially sweetened cannot be discounted. This study provides some insight into possible associations of HCC with sugary drinks intake. Further exploration in other settings is required.

Effects of Curcumin on Tobacco Smoke-induced Hepatic MAPK Pathway Activation and Epithelial-Mesenchymal TransitionIn Vivo

“…The incidence of liver cancer varies considerably by geographic region. In high‐risk areas, infectious hepatitis and dietary aflatoxin exposure are well‐documented risk factors for liver cancer (Stepien et al, ). However, other risk factors may play a larger role in low‐risk areas (Zhu et al, ).…”

Towards standardisation of evidence-based clinical care process specifications

“…Both these non-nutritive sweeteners have received sufficient research to suggest that the health dangers of frequent or daily use may also be harmful. [104][105][106] This example demonstrates our claims regarding policy that it is: (1) politically motivated, (2) often not based on established scientific evidence and (3) it tends towards having been constructed by politicians from many small sound bites seeking air time to expound the virtues of their policy and elicit support from the ordinary citizen.…”

Health outcomes of non-nutritive sweeteners: analysis of the research landscape

“…Three prospective cohort studies investigated the risk of lymphomas or other hematological malignancies [ 127 , 128 ], 1 assessed the risk of biliary tract cancer [ 129 ], 1 assessed cancer incidence in general [ 130 ], 1 assessed the risk of tumor multiplicity in treated bladder cancer patients [ 131 ], 1 investigated the 5-year survival rate in urinary bladder cancer patients [ 132 ], while 2 retrospective cohort studies assessed the risk of bladder cancer [ 112 , 133 ] (no significant associations were described in either of them).…”